Immune Privilege: The Microbiome and Uveitis
Immune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye t...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2020.608377/full |
id |
doaj-7ca7cc0d4b914a1fb6c365245a9a75e7 |
---|---|
record_format |
Article |
spelling |
doaj-7ca7cc0d4b914a1fb6c365245a9a75e72021-01-25T07:05:33ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-01-011110.3389/fimmu.2020.608377608377Immune Privilege: The Microbiome and UveitisChristine Mölzer0Jarmila Heissigerova1Heather M. Wilson2Lucia Kuffova3Lucia Kuffova4John V. Forrester5Institute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomDepartment of Ophthalmology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, CzechiaInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomEye Clinic, Aberdeen Royal Infirmary, Aberdeen, United KingdomInstitute of Medical Sciences, University of Aberdeen, Aberdeen, United KingdomImmune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye therefore displays a spectrum of IP because it comprises several tissues. IP as originally conceived can only apply to the retina as it contains few tissue-resident bone-marrow derived myeloid cells and is immunologically shielded by a sophisticated barrier – an inner vascular and an outer epithelial barrier at the retinal pigment epithelium. The vascular barrier comprises the vascular endothelium and the glia limitans. Immune cells do not cross the blood-retinal barrier (BRB) despite two-way transport of interstitial fluid, governed by tissue oncotic pressure. The BRB, and the blood-brain barrier (BBB) mature in the neonatal period under signals from the expanding microbiome and by 18 months are fully established. However, the adult eye is susceptible to intraocular inflammation (uveitis; frequency ~200/100,000 population). Uveitis involving the retinal parenchyma (posterior uveitis, PU) breaches IP, while IP is essentially irrelevant in inflammation involving the ocular chambers, uveal tract and ocular coats (anterior/intermediate uveitis/sclerouveitis, AU). Infections cause ~50% cases of AU and PU but infection may also underlie the pathogenesis of immune-mediated “non-infectious” uveitis. Dysbiosis accompanies the commonest form, HLA-B27–associated AU, while latent infections underlie BRB breakdown in PU. This review considers the pathogenesis of uveitis in the context of IP, infection, environment, and the microbiome.https://www.frontiersin.org/articles/10.3389/fimmu.2020.608377/fullT regulatory cellsfolateprobioticsblood retinal barrieradjuvant effectcommensals |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Christine Mölzer Jarmila Heissigerova Heather M. Wilson Lucia Kuffova Lucia Kuffova John V. Forrester |
spellingShingle |
Christine Mölzer Jarmila Heissigerova Heather M. Wilson Lucia Kuffova Lucia Kuffova John V. Forrester Immune Privilege: The Microbiome and Uveitis Frontiers in Immunology T regulatory cells folate probiotics blood retinal barrier adjuvant effect commensals |
author_facet |
Christine Mölzer Jarmila Heissigerova Heather M. Wilson Lucia Kuffova Lucia Kuffova John V. Forrester |
author_sort |
Christine Mölzer |
title |
Immune Privilege: The Microbiome and Uveitis |
title_short |
Immune Privilege: The Microbiome and Uveitis |
title_full |
Immune Privilege: The Microbiome and Uveitis |
title_fullStr |
Immune Privilege: The Microbiome and Uveitis |
title_full_unstemmed |
Immune Privilege: The Microbiome and Uveitis |
title_sort |
immune privilege: the microbiome and uveitis |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2021-01-01 |
description |
Immune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye therefore displays a spectrum of IP because it comprises several tissues. IP as originally conceived can only apply to the retina as it contains few tissue-resident bone-marrow derived myeloid cells and is immunologically shielded by a sophisticated barrier – an inner vascular and an outer epithelial barrier at the retinal pigment epithelium. The vascular barrier comprises the vascular endothelium and the glia limitans. Immune cells do not cross the blood-retinal barrier (BRB) despite two-way transport of interstitial fluid, governed by tissue oncotic pressure. The BRB, and the blood-brain barrier (BBB) mature in the neonatal period under signals from the expanding microbiome and by 18 months are fully established. However, the adult eye is susceptible to intraocular inflammation (uveitis; frequency ~200/100,000 population). Uveitis involving the retinal parenchyma (posterior uveitis, PU) breaches IP, while IP is essentially irrelevant in inflammation involving the ocular chambers, uveal tract and ocular coats (anterior/intermediate uveitis/sclerouveitis, AU). Infections cause ~50% cases of AU and PU but infection may also underlie the pathogenesis of immune-mediated “non-infectious” uveitis. Dysbiosis accompanies the commonest form, HLA-B27–associated AU, while latent infections underlie BRB breakdown in PU. This review considers the pathogenesis of uveitis in the context of IP, infection, environment, and the microbiome. |
topic |
T regulatory cells folate probiotics blood retinal barrier adjuvant effect commensals |
url |
https://www.frontiersin.org/articles/10.3389/fimmu.2020.608377/full |
work_keys_str_mv |
AT christinemolzer immuneprivilegethemicrobiomeanduveitis AT jarmilaheissigerova immuneprivilegethemicrobiomeanduveitis AT heathermwilson immuneprivilegethemicrobiomeanduveitis AT luciakuffova immuneprivilegethemicrobiomeanduveitis AT luciakuffova immuneprivilegethemicrobiomeanduveitis AT johnvforrester immuneprivilegethemicrobiomeanduveitis |
_version_ |
1724324603458748416 |